model
infecti
diseas
small
anim
major
tenet
biomed
research
report
detail
influenza
infect
mice
earli
mice
remain
wide
employ
model
respiratori
pathogenesi
today
due
numer
reagent
establish
protocol
short
reproduct
cycl
mice
also
allow
evalu
quantit
aspect
infect
includ
viral
replic
host
transcript
respons
immun
infiltr
suffici
number
gener
statist
robust
data
provid
inform
kinet
virul
mechan
otherwis
unavail
either
vitro
human
cohort
studi
find
form
foundat
knowledg
viral
respiratori
diseas
despit
expans
role
mous
model
sever
shortcom
regard
understand
human
diseas
viral
respiratori
infect
particular
concern
broad
transcript
dissimilar
requir
high
viral
dose
induc
measur
eg
weight
loss
diseas
mice
variat
pathogen
due
host
specif
factor
led
question
util
small
anim
model
howev
new
technolog
approach
includ
collabor
cross
human
mice
provid
stronger
link
mous
model
human
diseas
refin
measur
respiratori
function
eg
whole
bodi
plethysmographi
provid
novel
metric
diseas
respons
noninvas
assess
analyz
anim
throughout
cours
viral
infect
approach
present
major
opportun
understand
impact
viral
infect
breath
function
develop
novel
anim
model
emerg
viral
respiratori
pathogen
provid
link
human
diseas
especi
pathogen
caus
sever
morbid
mortal
respiratori
distress
current
work
util
infect
mous
adapt
sever
acut
respiratori
syndrom
coronaviru
sarscov
well
influenza
iav
isol
henceforth
refer
model
sever
acut
respiratori
diseas
sarscov
emerg
cov
circul
bat
civet
raccoon
dog
open
market
caus
sever
acut
respiratori
diseas
mortal
rate
exceed
age
popul
similarli
spring
novel
pandem
strain
emerg
infect
signific
portion
world
popul
caus
substanti
morbid
mortal
importantli
robust
mous
model
infect
exist
sarscov
iav
recapitul
clinic
aspect
diseas
found
human
use
whole
bodi
plethysmographi
individu
mice
longitudin
studi
data
demonstr
signific
chang
wide
varieti
respiratori
paramet
follow
viral
infect
measur
penh
rpef
vari
depend
dose
pathogen
throughout
time
cours
addit
chang
metric
correspond
even
preced
weight
loss
chang
lethal
tradit
measur
pathogenesi
final
follow
acut
phase
infect
chang
measur
remain
indic
respiratori
viru
infect
impact
breath
function
beyond
normal
acut
infect
togeth
result
highlight
util
examin
respiratori
function
via
whole
bodi
plethysmographi
within
context
acut
respiratori
infect
viral
titrat
propag
sarscov
influenza
virus
preform
mdck
cell
respect
use
standard
method
wildtyp
wt
mous
adapt
infecti
clone
ic
sarscov
deriv
baric
laboratori
ic
construct
influenza
deriv
plasmidbas
reversegenet
system
subsequ
amplifi
mdck
cell
week
old
anim
order
jackson
lab
bar
harbor
anim
brought
biosafeti
lab
level
allow
acclim
week
prior
infect
infect
mice
anesthet
mixtur
ketamin
xylazin
infect
intranas
challeng
phosphatebuff
salin
pb
dilut
viru
sarscov
iav
three
four
mice
per
infect
group
per
dose
describ
figur
legend
per
anim
protocol
anim
monitor
daili
clinic
sign
diseas
hunch
ruffl
fur
reduc
activ
durat
experi
weight
loss
monitor
daili
first
day
weight
monitor
continu
anim
recov
initi
start
weight
display
three
continu
day
weight
gain
mice
lose
greater
start
bodi
weight
ground
fed
monitor
multipl
time
per
day
long
cutoff
mice
lose
greater
start
bodi
weight
immedi
sacrif
per
protocol
mous
deem
moribund
unlik
recov
also
humanli
sacrif
discret
research
euthanasia
preform
via
isofluran
overdos
confirm
death
cervic
disloc
mous
studi
perform
univers
north
carolina
anim
welfar
assur
use
protocol
approv
unc
institut
anim
care
use
committe
iacuc
anim
anesthet
mixtur
ketaminexylezin
viru
inoculum
dilut
appropri
concentr
phosphat
buffer
salin
introduc
intranas
volum
microlit
dose
curv
sarscov
infect
plaqu
form
unit
per
microlit
expand
time
cours
infecti
dose
sarscov
plaqu
form
unit
per
microlit
anim
individu
introduc
plethysmographi
chamber
buxco
system
wilmington
nc
locat
within
biolog
safeti
cabinet
acclim
minut
follow
acclim
anim
activ
measur
minut
period
anim
introduc
chamber
per
day
first
introduct
plethysmographi
chamber
immedi
prior
infect
thereaft
indic
time
point
post
infect
anim
randomli
assign
given
chamber
day
statist
data
analysi
conduct
within
r
environ
cranrprojectorg
packag
dobi
use
data
manipul
mass
use
data
transform
normal
mixedeffect
statist
analys
data
visual
measur
period
within
plethysmograph
plethysmograph
continu
measur
respiratori
respons
output
data
summari
variou
respiratori
measur
shown
fig
tabl
well
sever
data
qualiti
controal
metric
output
data
examin
transform
normal
use
boxcox
approach
within
day
measur
period
sequenti
measur
provid
increas
inform
anim
respiratori
function
well
causal
relationship
respiratori
metric
examin
perday
anim
averag
measur
data
time
uncar
util
sequenti
measur
result
inflat
statist
signific
therefor
settl
partial
ftest
framework
analog
model
select
approach
specif
first
fit
mix
effect
null
model
respiratorymeasureday
day
continu
independ
fix
effect
subject
random
effect
approach
allow
uniqu
animaltoanim
physiolog
account
well
daili
variat
measur
account
contrast
null
model
test
model
respiratorymeasuredaytreat
contrast
test
allow
us
specif
determin
standard
pvalu
assess
signific
treatment
effect
eg
viral
pathogen
viral
dose
significantli
increas
fit
reduc
error
estim
statist
model
alreadi
account
daili
animalspecif
effect
signific
overal
effect
treatment
respiratori
respons
seen
throughout
cours
infect
use
similar
framework
within
day
determin
time
point
post
infect
bonferonni
correct
p
signific
effect
treatment
posthoc
comparison
made
use
tukey
hsd
approach
identifi
treatment
group
eg
mock
versu
fluinfect
versu
sarsinfect
differ
specif
differ
given
timepoint
present
studi
carri
accord
recommend
care
use
anim
offic
laboratori
anim
welfar
nation
institut
health
institut
anim
care
use
committe
iacuc
univers
north
carolina
chapel
hill
unc
permit
approv
anim
studi
protocol
iacuc
follow
studi
built
upon
well
establish
infect
model
sarscov
util
mous
adapt
viru
old
mice
produc
rang
dosedepend
diseas
includ
robust
viral
titer
lung
weight
loss
histolog
damag
mortal
initi
result
studi
confirm
previous
report
dosedepend
chang
weight
loss
fig
surviv
fig
concurr
also
util
whole
bodi
plethysmographi
buxco
measur
respiratori
paramet
context
infect
sevenday
time
cours
tabl
plethysmographi
output
includ
varieti
primari
respiratori
measur
eg
frequenc
tidal
volum
inspiratoryexpiratori
flow
rate
well
deriv
respiratori
measur
eg
airflow
resist
summar
tabl
provid
novel
metric
evalu
impact
viral
infect
respiratori
function
importantli
complex
correl
structur
respiratori
measur
provid
extens
depth
describ
pathogenesi
follow
infect
fig
tabl
studi
focus
three
specif
metric
chang
context
infect
penh
rpef
first
respiratori
metric
focus
enhanc
paus
penh
unitless
index
calcul
airway
function
equat
penh
fig
take
account
four
breath
paramet
includ
peak
expiratori
flow
breath
pef
peak
inspiratori
flow
breath
pif
time
expiratori
portion
breath
te
time
requir
exhal
breath
volum
tr
novel
metric
vivo
infect
penh
deriv
mous
whole
bodi
plethysmographi
without
controversi
asthma
field
support
suggest
penh
serv
indirect
measur
airway
resist
critic
argu
fail
measur
airway
constrict
best
provid
nonspecif
assess
breath
pattern
studi
sarscov
infect
result
dose
respons
chang
penh
valu
fig
mockinfect
anim
maintain
baselin
level
sarscov
infect
dose
produc
increas
penh
valu
earli
portion
infect
time
cours
pef
pif
tr
valu
show
variabl
chang
penh
primarili
driven
increas
te
sarscov
infect
fig
importantli
increas
penh
correspond
case
dose
preced
chang
weight
loss
fig
provid
addit
metric
onset
pathogenesi
notabl
studi
show
high
valu
greater
sustain
valu
penh
exceed
previous
report
valu
viral
asthma
airway
respons
studi
typic
result
transit
level
penh
rang
mock
anim
typic
show
valu
time
cours
continu
penh
valu
also
began
declin
dosedepend
manner
remain
significantli
elev
termin
experi
despit
surround
controversi
penh
provid
novel
respiratori
metric
pathogenesi
context
sarscov
infect
highli
discrimin
variat
viral
dose
also
correspond
andor
preced
chang
weight
loss
second
respiratori
metric
focus
midtid
expiratori
flow
valu
repres
flow
rate
tidal
volum
individu
breath
expel
measur
millilit
per
second
bear
similar
forc
expiratori
flow
standard
measur
human
spirometri
differ
wave
form
magnitud
natur
forc
breath
make
comparison
difficult
despit
differ
measur
provid
insight
earli
portion
breath
curv
typic
vivo
asthma
studi
examin
respiratori
function
observ
reduc
level
report
percent
reduct
rel
baselin
result
breath
curv
shift
right
reduc
flow
rate
requir
time
exhal
volum
fig
howev
valu
increas
robustli
sarscov
infect
compar
mock
maximum
differ
occur
day
post
infect
dpi
fig
kinet
vari
base
condit
dose
induc
rapid
increas
mainten
high
level
throughout
time
cours
infect
data
indic
sarscov
infect
breath
curv
shift
left
rapidli
exhal
breath
volum
fig
togeth
result
repres
strike
contrast
prior
studi
examin
airway
function
context
allerg
respons
addit
detect
differ
sarscov
infect
group
indic
dose
depend
kinet
may
distinguish
diseas
sever
prior
pathogen
marker
like
weight
loss
lethal
final
respiratori
metric
focus
rpef
ratio
time
peak
expiratori
flow
pef
rel
total
expiratori
time
te
similar
penh
rpef
provid
calcul
index
breath
curv
combin
time
need
reach
maximum
expiratori
flow
divid
total
length
breath
fig
less
util
previou
two
metric
rpef
valu
shown
increas
context
hypoxia
vivo
howev
studi
sarscov
infect
result
robust
declin
rpef
rel
mock
control
remain
static
time
cours
fig
similar
kinet
penh
reduct
rpef
valu
correspond
dose
preced
chang
weight
loss
time
cours
continu
rpef
recoveri
equival
dose
diverg
thereaft
examin
underli
respiratori
paramet
reveal
rapid
time
pef
follow
sarscov
infect
consist
previou
studi
hypoxia
howev
increas
time
pef
also
correspond
longer
breath
te
result
increas
denomin
ratio
drive
signific
reduct
rpef
valu
importantli
kinet
rpef
respons
illustr
dose
depend
impact
sarscov
infect
provid
third
clinic
relev
respiratori
metric
evalu
pathogenesi
vivo
order
valid
well
expand
find
conduct
addit
experi
explor
differ
respiratori
pathogen
well
longterm
impact
breath
function
use
semileth
dose
compar
sarscov
human
isol
influenza
viru
pfu
day
time
cours
base
previou
studi
weight
loss
sarscov
occur
primarili
post
infect
fig
contrast
weight
loss
delay
major
weight
loss
occur
post
infect
tabl
regard
respiratori
metric
virus
show
similar
overal
magnitud
penh
rpef
respons
fig
tabl
similarli
show
evid
enhanc
sar
flu
infect
rel
mock
anim
tabl
howev
kinet
respons
curv
vari
sarscov
show
earlier
chang
resolut
compar
initi
experi
virus
chang
respiratori
physiolog
correspond
weight
loss
confirm
previous
observ
pathogenesi
trend
regard
histopatholog
score
tabl
contrast
prior
studi
also
abl
identifi
signific
longterm
chang
respiratori
metric
follow
infect
despit
recoveri
infectioninduc
weight
loss
far
day
post
infect
penh
rpef
level
remain
significantli
differ
observ
mock
anim
result
suggest
despit
absenc
metric
pathogenesi
breath
function
requir
addit
recoveri
time
may
return
baselin
level
follow
respiratori
viru
infect
might
provid
insight
chronic
secondaryinfect
respons
attribut
sar
iav
contrast
tradit
measur
respiratori
viru
pathogenesi
examin
breath
function
repres
novel
clinic
relev
metric
diseas
follow
infect
studi
illustr
signific
chang
sever
respiratori
paramet
includ
penh
rpef
follow
sarscov
infect
importantli
respiratori
measur
track
time
preced
tradit
measur
diseas
pathogenesi
includ
weight
loss
lethal
also
appear
independ
viral
load
observ
respiratori
metric
provid
increas
depth
pathogenesi
studi
addit
impact
respiratori
function
extend
beyond
acut
infect
extens
current
captur
tradit
metric
pathogenesi
togeth
examin
respiratori
measur
provid
novel
insight
onset
sever
kinet
diseas
respons
robust
across
two
viral
pathogen
improv
tie
measur
human
respiratori
function
gave
insight
function
outcom
viru
infect
mani
experiment
studi
interpret
respiratori
metric
complic
indirect
parallel
human
pulmonari
function
test
human
test
primarili
util
measur
forc
breath
similar
metric
appli
vivo
studi
mice
despit
differ
import
insight
infect
ascertain
time
length
breath
te
increas
peak
time
diseas
follow
sarscov
iav
infect
chang
te
drove
differ
observ
infect
mock
treat
anim
captur
penh
rpef
fig
surprisingli
despit
increas
length
breath
flow
rate
expir
earli
part
breath
also
increas
captur
highli
correl
pef
fig
coupl
faster
time
reach
peak
flow
rate
rpef
data
suggest
viral
infect
result
rapid
exhal
major
air
volum
howev
remaind
volum
take
longer
releas
analog
wheez
observ
human
appli
tradit
descript
human
airway
diseas
metric
appear
overlap
element
restrict
obstruct
airway
diseas
pattern
crossreferenc
observ
sarscov
infect
damag
debri
infect
lung
epithelia
coupl
infiltr
immun
popul
shown
enhanc
fibrinosi
wound
heal
respons
vivo
expect
impact
lung
would
decreas
pulmonari
complianc
ie
stiff
possibl
result
rapid
flow
rate
earli
portion
breath
reduc
rate
toward
end
elong
time
breath
therefor
respiratori
metric
measur
studi
like
consist
observ
pathogenesi
human
illustr
util
follow
valu
measur
pathogenesi
rpef
rel
novel
respiratori
metric
enhanc
paus
penh
longer
controversi
histori
within
asthma
field
use
penh
marker
resist
debat
support
use
sever
way
result
interpret
seek
independ
controversi
typic
asthma
studi
use
methacholin
allergen
induc
immedi
acut
airway
constrict
studi
requir
prime
anim
beyond
initi
infect
penh
valu
observ
track
time
preced
classic
measur
pathogenesi
diseas
fig
importantli
penh
peak
close
correspond
peak
level
viral
replic
airway
denud
debri
sarscov
iav
tabl
importantli
airflow
chang
maintain
sever
day
rather
minut
observ
asthma
studi
final
observ
kinet
penh
vari
base
pathogen
indic
chang
due
artifact
whole
bodi
plethysmographi
system
modest
drop
penh
time
cours
track
clear
airway
also
increas
inflamm
cellular
infiltr
togeth
data
indic
penh
correspond
histolog
marker
pathogenesi
vivo
addit
result
suggest
infecti
diseas
airway
denud
debri
context
high
viral
replic
like
provid
major
mechan
contribut
airway
resist
contrast
role
airway
constrict
airway
resist
asthma
futur
studi
directli
contrast
unrestrain
plethysmographi
approach
direct
measur
airway
resist
eg
forc
ventil
may
provid
use
insight
rel
role
constrict
tissu
damag
respiratori
distress
follow
viral
infect
regardless
ultim
function
mechan
penh
clearli
provid
use
character
alter
respiratori
function
differenti
pathogen
follow
infect
vivo
addit
respiratori
pathogenesi
marker
provid
opportun
character
infect
revolution
understand
diseas
develop
novel
therapuet
treatment
captur
respiratori
metric
infect
new
novel
strain
expand
beyond
system
marker
like
weight
loss
lethal
depth
permit
classif
attenu
provid
opportun
identifi
natur
patholog
function
disntiguish
strain
exampl
previou
studi
use
differ
plethysmographi
output
influenza
infect
anim
demonstr
dose
strain
depend
differ
captur
weight
loss
alon
similar
plethysmographi
studi
provid
addit
metric
distinguish
lethal
subleth
diseas
phenotyp
follow
influenza
result
consist
data
sarscov
expand
upon
singl
dose
influeza
studi
describ
manuscript
togeth
result
demonstr
util
employ
plethysmographi
baselin
pathogenesi
studi
addit
whole
bodi
plethysmographi
util
explor
impact
attenu
mutat
vivo
use
whole
bodi
plethysmographi
studi
demonstr
attenu
restor
methyltransferas
mutant
sarscov
term
respiratori
function
addit
deficit
weight
loss
viral
titer
find
spur
applic
mutant
live
attenu
vaccin
platform
least
partial
due
minim
disrupt
respiratori
function
similar
approach
novel
emerg
virus
provid
opportun
fulli
examin
respiratori
function
determin
pathogensi
potenti
addit
character
physiolog
mechan
underli
sever
viral
infect
respiratori
metric
may
also
provid
insight
treatment
resolut
longterm
physiolog
impact
infect
drug
target
focu
reduc
viral
replicationinfect
modul
host
respons
may
provid
better
mean
allevi
acut
downstream
impact
infect
howev
tradit
metric
pathogenesi
like
weight
loss
viral
titer
appropri
measur
type
evalu
instead
respiratori
metric
like
penh
rpef
provid
opportun
evalu
treatment
target
host
pathway
impact
overal
infect
exampl
immun
patholog
hallmark
pathogen
respiratori
viru
diseas
number
treatment
option
target
host
pathway
includ
complement
urokinas
pathway
wound
repair
process
may
reduc
immun
patholog
independ
viral
replic
improv
lung
function
similarli
measur
use
evlaut
kinet
treatment
identifi
ideal
window
applic
base
respiratori
outcom
importantli
examin
penh
rpef
lead
treatment
option
look
beyond
acut
infect
improv
longterm
lung
function
especi
import
highli
vulner
elderli
popul
small
signific
chang
note
longterm
baselin
function
penh
rpef
fig
minor
chang
young
mice
like
expand
age
anim
may
contribut
age
relat
susceptibl
observ
mice
human
togeth
result
provid
metric
respres
opportun
understand
improv
treatment
diseas
follow
respiratori
viru
infect
overal
current
work
highlight
util
examin
physiolog
metric
infect
specif
whole
bodi
plethysmographi
context
virul
respiratori
viru
infect
sarscov
iav
distinct
respiratori
chang
occur
follow
infect
new
metric
provid
increas
depth
understand
regard
pathogenesi
point
underli
function
mechan
remain
unclear
valu
penh
rpef
illustr
concord
increas
sensit
compar
tradit
marker
pathogenesi
importantli
respiratori
metric
also
demonstr
longterm
impact
infect
lung
function
current
captur
pathogenesi
marker
final
examin
lung
function
mice
provid
import
link
human
respiratori
diseas
may
facilit
treatment
option
target
host
process
order
improv
respir
infect
togeth
result
highlight
util
potenti
examin
whole
bodi
plethysmographi
within
context
acut
respiratori
viru
infect
vivo
